Compounds selected from the group of compounds represented by formula I: ##STR1## where: R.sub.10 is represented by the formula (A), (B), or (C): ##STR2## R.sub.20 is represented by the formula (U), (V), or (W): ##STR3## and the other substituents are as defined in the specification; and their pharmaceutically acceptable salts; are inhibitors of prostaglandin G/H synthase and are anti-inflammatory and analgesic agents.
从由式I表示的化合物组中选择的化合物:##STR1##其中:R.sub.10由式(A)、(B)或(C)表示:##STR2##R.sub.20由式(U)、(V)或(W)表示:##STR3##其他取代基如规范中定义;及其药学上可接受的盐;是
前列腺素G/H合酶的
抑制剂,具有抗炎和镇痛作用。